These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32889007)

  • 1. The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity.
    Pozzi E; Fumagalli G; Chiorazzi A; Canta A; Meregalli C; Monza L; Carozzi VA; Oggioni N; Rodriguez-Menendez V; Cavaletti G; Marmiroli P
    Exp Neurol; 2020 Dec; 334():113458. PubMed ID: 32889007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
    Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
    Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice.
    Calls A; Torres-Espin A; Tormo M; Martínez-Escardó L; Bonet N; Casals F; Navarro X; Yuste VJ; Udina E; Bruna J
    Ann Clin Transl Neurol; 2022 Dec; 9(12):1985-1998. PubMed ID: 36369764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and Neuropathic Gene Expression Signatures of Chemotherapy-Induced Neuropathy Induced by Vincristine, Cisplatin, and Oxaliplatin in C57BL/6J Mice.
    Starobova H; Mueller A; Deuis JR; Carter DA; Vetter I
    J Pain; 2020; 21(1-2):182-194. PubMed ID: 31260808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.
    Cavaletti G; Petruccioli MG; Marmiroli P; Rigolio R; Galbiati S; Zoia C; Ferrarese C; Tagliabue E; Dolci C; Bayssas M; Griffon Etienne G; Tredici G
    Anticancer Res; 2002; 22(6C):4199-204. PubMed ID: 12553056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.
    Cavaletti G; Tredici G; Petruccioli MG; Dondè E; Tredici P; Marmiroli P; Minoia C; Ronchi A; Bayssas M; Etienne GG
    Eur J Cancer; 2001 Dec; 37(18):2457-63. PubMed ID: 11720843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.
    Carozzi VA; Canta A; Oggioni N; Sala B; Chiorazzi A; Meregalli C; Bossi M; Marmiroli P; Cavaletti G
    Exp Neurol; 2010 Dec; 226(2):301-9. PubMed ID: 20832406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors.
    Potenzieri A; Riva B; Rigolio R; Chiorazzi A; Pozzi E; Ballarini E; Cavaletti G; Genazzani AA
    Pain; 2020 Feb; 161(2):405-415. PubMed ID: 31634341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ameliorative effects of aqueous extract of Forsythiae suspensa fruits on oxaliplatin-induced neurotoxicity in vitro and in vivo.
    Yi JM; Shin S; Kim NS; Bang OS
    BMC Complement Altern Med; 2019 Nov; 19(1):339. PubMed ID: 31783843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study.
    Attal N; Bouhassira D; Gautron M; Vaillant JN; Mitry E; Lepère C; Rougier P; Guirimand F
    Pain; 2009 Aug; 144(3):245-252. PubMed ID: 19457614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
    Wei G; Gu Z; Gu J; Yu J; Huang X; Qin F; Li L; Ding R; Huo J
    J Peripher Nerv Syst; 2021 Mar; 26(1):35-42. PubMed ID: 33462873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies.
    Calls A; Carozzi V; Navarro X; Monza L; Bruna J
    Exp Neurol; 2020 Mar; 325():113141. PubMed ID: 31865195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of oxaliplatin-related neurotoxicity by ω-3 PUFAs: A double-blind randomized study of patients receiving oxaliplatin combined with capecitabine for colon cancer.
    Zhang X; Chen H; Lu Y; Xu C; Yao W; Xu L; Zhang R; Zhang L; Yao Q
    Medicine (Baltimore); 2020 Dec; 99(50):e23564. PubMed ID: 33327312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function.
    Yang Y; Luo L; Cai X; Fang Y; Wang J; Chen G; Yang J; Zhou Q; Sun X; Cheng X; Yan H; Lu W; Hu C; Cao P
    Free Radic Biol Med; 2018 May; 120():13-24. PubMed ID: 29530794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: The role of nerve excitability testing.
    Chiorazzi A; Canta A; Carozzi VA; Meregalli C; Pozzi E; Ballarini E; Rodriguez-Menendez V; Marmiroli P; Cavaletti G; Alberti P
    J Peripher Nerv Syst; 2024 Mar; 29(1):47-57. PubMed ID: 38009865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous extract of Lithospermi radix attenuates oxaliplatin-induced neurotoxicity in both in vitro and in vivo models.
    Cho ES; Yi JM; Park JS; Lee YJ; Lim CJ; Bang OS; Kim NS
    BMC Complement Altern Med; 2016 Oct; 16(1):419. PubMed ID: 27782842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity.
    Argyriou AA; Antonacopoulou AG; Alberti P; Briani C; Bruna J; Velasco R; Anastopoulou GG; Park SB; Cavaletti G; Kalofonos HP
    J Peripher Nerv Syst; 2019 Dec; 24(4):298-303. PubMed ID: 31486252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin reduces c-Fos and ATF3 expression in the dorsal root ganglia and protects against oxaliplatin-induced peripheral sensory neuropathy in mice.
    Pereira AF; Pereira LMS; Silva CMP; Freitas Alves BW; Barbosa JS; Pinto FMM; Pereira AC; Silva KO; Pontes RB; Alencar NMN; Lima-Júnior RCP; Vale ML
    Neurosci Lett; 2019 Sep; 709():134378. PubMed ID: 31325582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
    Joseph EK; Chen X; Bogen O; Levine JD
    J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer.
    Wang DS; Wang ZQ; Chen G; Peng JW; Wang W; Deng YH; Wang FH; Zhang JW; Liang HL; Feng F; Xie CB; Ren C; Jin Y; Shi SM; Fan WH; Lu ZH; Ding PR; Wang F; Xu RH; Li YH
    Cancer Med; 2020 Jan; 9(1):151-159. PubMed ID: 31724334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.